Women's Health Archives - Endocrinology Advisor

Women’s Health

NDA for Twirla Contraceptive Patch Resubmitted to FDA

Agile Therapeutics has resubmitted to the Food and Drug Administration (FDA) the New Drug Application (NDA) for its product, Twirla, an investigational low-dose combined hormonal contraceptive patch (AG200-15). Based on the results from a comparative wear study, the resubmitted NDA will address the FDA’s questions on in vivo adhesion, additional information on the Company’s manufacturing…

Portrait of sleeping newborn twins

Prenatal Testosterone Exposure Reduces Socioeconomic Success, Fertility of Female Co-Twins

Women exposed to a male co-twin in utero have decreased probability of fertility and socioeconomic success, according to study findings published in PNAS. For this study, researchers constructed a multivariable linear regression model to study the long-term effects of testosterone transfer in females who are opposite-sex co-twins. The model was designed using a longitudinal data…

Next post in Practice Management